Dr. Lenz on Need for New Treatment Strategies in Colorectal Cancer

Heinz-Josef Lenz, MD, FACP
Published Online: Friday, Aug 11, 2017



Heinz-Josef Lenz, MD, FACP, associate director for Adult Oncology and co-leader of the Gastrointestinal Cancers Program, USC Norris Comprehensive Cancer Center, discusses the need for new treatment strategies in colorectal cancer (CRC).

Immunotherapies are providing a long-lasting duration of response in certain patients with CRC—breaking from the typical course of chemotherapy in this disease.

As for new treatments, Lenz says that a stem cell-targeting approach may be the most effective treatment to potentially cure patients.
 


Heinz-Josef Lenz, MD, FACP, associate director for Adult Oncology and co-leader of the Gastrointestinal Cancers Program, USC Norris Comprehensive Cancer Center, discusses the need for new treatment strategies in colorectal cancer (CRC).

Immunotherapies are providing a long-lasting duration of response in certain patients with CRC—breaking from the typical course of chemotherapy in this disease.

As for new treatments, Lenz says that a stem cell-targeting approach may be the most effective treatment to potentially cure patients.
 



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 1st Annual European Congress on Immunotherapies in Cancer™Dec 13, 20171.5
Community Practice Connections™: The Emergence of CAR-T Cell Therapy for Hematologic Malignancies: Moving From Bench to BedsideDec 29, 20171.5
Publication Bottom Border
Border Publication
x